Interferon-alpha: A key cytokine in systemic lupus erythematosus pathogenesis;Interféron-alpha : une cytokine clé dans la physiopathologie du lupus systémique

Revue de Medecine Interne

Volumn 29, Issue 9, 2008, Pages 696-700

  Mathian, A ^a   Koutouzov, S ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Glomerulonephritis; Interferon alpha; Lupus

Indexed keywords

ALPHA INTERFERON; CYTOKINE;

AUTOIMMUNE DISEASE; CHRONIC INFLAMMATION; CLINICAL FEATURE; DISEASE COURSE; DNA POLYMORPHISM; GENETIC VARIABILITY; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN PURIFICATION; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; ARTICLE; BLOOD; IMMUNOLOGY; PHYSIOLOGY;

HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 49849093534     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.04.011     Document Type: Short Survey

References (26)

1. Stewart T.A. Neutralizing interferon-alpha as a therapeutic approach to autoimmune diseases. Cytokine Growth Factor Rev 14 (2003) 139-154
2. Theofilopoulos A.N., Baccala R., Beutler B., and Kono D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Ann Rev Immunol 23 (2005) 307-336
3. Banchereau J., and Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25 (2006) 383-392
4. Ronnblom L., Eloranta M.L., and Alm G.V. Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity 36 (2003) 463-472
5. Der S.D., Zhou A., Williams B.R., and Silverman R.H. Identification of genes differentially regulated by interferon-alpha, -beta, or -gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 95 (1998) 15623-15628
6. Skurkovich S.V., and Eremkina E.I. The probable role of interferon in allergy. Ann Allergy 35 (1975) 356-360
7. Gresser I., Maury C., Tovey M., Morel-Maroger L., and Pontillon F. Progressive glomerulonephritis in mice treated with interferon preparations at birth. Nature 263 (1976) 420-422
8. Gresser J., Morel-Maroger L., Verroust P., Riviere Y., and Guillon J.C. Anti-interferon globulin inhibits the development of glomerulonephritis in mice infected at birth with lymphocytic choriomeningitis virus. Proc Natl Acad Sci U S A 75 (1978) 3413-3416
9. Shiozawa S., Kuroki Y., Kim M., Hirohata S., and Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum 35 (1992) 417-422
10. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100 (2003) 2610-2615
11. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197 (2003) 711-723
12. Papo T. Interéféron-alpha et auto-immunité. Rev Med Interne 23 suppl. 4 (2002) 501s-510s
13. Ronnblom L.E., Alm G.V., and Oberg K. Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment. Acta Oncol 30 (1991) 537-540
14. Okanoue T., Sakamoto S., Itoh Y., Minami M., Yasui K., SakamotoM, et al. Side-effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 25 (1996) 283-291
15. Santiago-Raber M.L., Baccala R., Haraldsson K.M., Choubey D., Stewart T.A., Kono D.H., et al. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 197 (2003) 777-788
16. Braun D., Geraldes P., and Demengeot J. Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice. J Autoimmun 20 (2003) 15-25
17. Mathian A., Weinberg A., Gallegos M., Banchereau J., and Koutouzov S. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black × New Zealand White) F1 but not in BALB/c mice. J Immunol 174 (2005) 2499-2506
18. Ronnblom L., and Alm G.V. Systemic lupus erythematosus and the type I interferon system. Arthritis Res Ther 5 (2003) 68-75
19. Zhuang H., Kosboth M., Lee P., Rice A., Driscoll D.J., Zori R., et al. Lupus-like disease and high interferon levels corresponding to trisomy of the type I interferon cluster on chromosome 9p. Arthritis Rheum 54 (2006) 1573-1579
20. Graham R.R., Kozyrev S.V., Baechler E.C., Reddy M.V., Plenge R.M., Bauer J.W., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38 (2006) 550-555
21. Sigurdsson S., Nordmark G., Göring H.H., Lindroos K., Wiman A.C., Sturfelt G., et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76 (2005) 528-537
22. Demirci F.Y., Manzi S., Ramsey-Goldman R., Minster R.L., Kenney M., Shaw P.S., et al. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE). Ann Hum Genet 71 (2006) 308-311
23. Barrat F.J., Meeker T., Gregorio J., Chan J.H., Akira S., Chang B., et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202 (2005) 1131-1139
24. Dong L., Ito S., Ishii K.J., and Klinman D.M. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice. Arthritis Rheum 52 (2005) 651-658
25. Blomberg S., Eloranta M.L., Magnusson M., Alm G.V., and Ronnblom L. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 48 (2003) 2524-2532
26. Vilcek J. Fifty years of interferon research: aiming at a moving target. Immunity 25 (2006) 343-348